Outlook Therapeutics, Inc.

Outlook Therapeutics, Inc. - Dividend Yieldverified

OTLK

Price:

$1.58

Market Cap:

$65.00M

Outlook Therapeutics, Inc. is a biopharmaceutical company in the advanced stages of clinical development, focused on inventing and bringing to market monoclonal antibody treatments for various eye conditions. Its flagship drug candidate, ONS-5010, is an ophthalmic formulation of bevacizumab currently undergoing crucial Phase III clinical trials. This investigational product is being evaluated for its potential to treat wet age-related macular degeneration and other serious retinal diseases. The company has forged strategic collaboration and licensing agreements with several partners, including IPCA Laboratories Limited, Laboratorios Liomont, S.A. de C.V., BioLexis Pte. Ltd., and Zhejiang Hua...[Read more]

Industry

Biotechnology

IPO Date

2016-06-14

Stock Exchange

NASDAQ

Ticker

OTLK

The Dividend Yield as of June 2026 (TTM) for Outlook Therapeutics, Inc. (OTLK) is 0%

According to Outlook Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Outlook Therapeutics, Inc. (OTLK) Historical Dividend Yield (quarterly & annually)

How has OTLK Dividend Yield performed in the past?

The mean historical Dividend Yield of Outlook Therapeutics, Inc. over the last ten years is 786.60%. The current 0% Dividend Yield has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), OTLK's Dividend Yield was at its highest in in the September 2019 quarter at 1.47%. The Dividend Yield was at its lowest in in the June 2016 quarter at 0%.

Quarterly (TTM)
Annual

Average

786.60%

Median

0%

Minimum

0%

Maximum

7.81%

Outlook Therapeutics, Inc. (OTLK) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Outlook Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 7.81%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20250%0%
20240%0%
20230%0%
20220%0%
20210%0%
20200%0%
20190%-100.00%
20187.81%15.04%
201751.61%Infinity%
20160%0%

Outlook Therapeutics, Inc. (OTLK) Average Dividend Yield

How has OTLK Dividend Yield performed in the past?

The current Dividend Yield of Outlook Therapeutics, Inc. (OTLK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

786.60%

Outlook Therapeutics, Inc. (OTLK) Dividend Yield vs. Peers

How is OTLK’s Dividend Yield compared to its peers?

Outlook Therapeutics, Inc.’s Dividend Yield is less than Spruce Biosciences, Inc. (0%), less than NRx Pharmaceuticals, Inc. (0%), less than Cue Biopharma, Inc. (0%), less than Werewolf Therapeutics, Inc. (0%), less than IO Biotech, Inc. (0%), less than OS Therapies Incorporated (0%), less than Coeptis Therapeutics, Inc. (0%), less than Equillium, Inc. (0%), less than Century Therapeutics, Inc. (0%), less than Medicus Pharma Ltd. Common Stock (0%),

Build a custom stock screener for Outlook Therapeutics, Inc. (OTLK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Outlook Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Outlook Therapeutics, Inc. (OTLK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Outlook Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is Outlook Therapeutics, Inc.'s Dividend Yield?

How is the Dividend Yield calculated for Outlook Therapeutics, Inc. (OTLK)?

What is the highest Dividend Yield for Outlook Therapeutics, Inc. (OTLK)?

What is the 3-year average Dividend Yield for Outlook Therapeutics, Inc. (OTLK)?

What is the 5-year average Dividend Yield for Outlook Therapeutics, Inc. (OTLK)?

How does the current Dividend Yield for Outlook Therapeutics, Inc. (OTLK) compare to its historical average?